pI: 7.7306 |
Length (AA): 438 |
MW (Da): 46245 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128557)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_53275 | sterol carrier protein |
Caenorhabditis elegans | CELE_Y57A10C.6 | Protein DAF-22 |
Drosophila melanogaster | Dmel_CG17597 | CG17597 gene product from transcript CG17597-RB |
Drosophila melanogaster | Dmel_CG17320 | Sterol carrier protein X-related thiolase |
Homo sapiens | ENSG00000116171 | sterol carrier protein 2 |
Leishmania braziliensis | LbrM.23.0840 | 3-ketoacyl-CoA thiolase, putative |
Leishmania donovani | LdBPK_230860.1 | 3-ketoacyl-CoA thiolase-like protein |
Leishmania infantum | LinJ.23.0860 | 3-ketoacyl-CoA thiolase, putative |
Leishmania major | LmjF.23.0690 | 3-ketoacyl-CoA thiolase, putative |
Leishmania mexicana | LmxM.23.0690 | 3-ketoacyl-CoA thiolase-like protein |
Loa Loa (eye worm) | LOAG_16226 | hypothetical protein |
Loa Loa (eye worm) | LOAG_15893 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13682 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13329 | hypothetical protein |
Loa Loa (eye worm) | LOAG_12152 | hypothetical protein |
Loa Loa (eye worm) | LOAG_15100 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13959 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14544 | hypothetical protein |
Mus musculus | ENSMUSG00000028603 | sterol carrier protein 2, liver |
Mycobacterium tuberculosis | Rv0914c | Possible lipid carrier protein or keto acyl-CoA thiolase |
Mycobacterium tuberculosis | Rv2790c | Probable lipid-transfer protein Ltp1 |
Mycobacterium ulcerans | MUL_4955 | lipid-transfer protein Ltp1 |
Mycobacterium ulcerans | MUL_2143 | lipid-transfer protein |
Schmidtea mediterranea | mk4.002756.03 | Non-specific lipid-transfer protein-like |
Schmidtea mediterranea | mk4.003829.02 | |
Schmidtea mediterranea | mk4.005896.01 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.023837.01 | Non-specific lipid-transfer protein-like |
Schmidtea mediterranea | mk4.025329.00 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.078445.00 | |
Schmidtea mediterranea | mk4.049830.00 | Non-specific lipid-transfer protein-like |
Schmidtea mediterranea | mk4.016650.00 | |
Schmidtea mediterranea | mk4.007043.00 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.030657.00 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.003904.00 | |
Trypanosoma brucei | Tb927.8.2540 | 3-ketoacyl-CoA thiolase, putative |
Trypanosoma cruzi | TcCLB.510507.20 | 3-ketoacyl-CoA thiolase, putative |
Trypanosoma cruzi | TcCLB.509463.30 | 3-ketoacyl-CoA thiolase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2837 | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu930 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.8.2540 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2540 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2540 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.2540 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y57A10C.6 | Caenorhabditis elegans | larval arrest | wormbase |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | sterol carrier protein 2 | Compounds | References |
2 literature references were collected for this gene.